Treatment as Prevention: Frequently Asked Questions
This FAQ was developed with input from the National Empowerment Network of People Living with HIV (NEPHAK) and Health GAP on the basis of national PLHIV dialogues on treatment as prevention conducted throughout Kenya. The questions and answers contain information relevant for a global audience—but have been written specifically for individuals living and working in low and middle income countries.
- What is new about treatment as prevention?
- When should PLHIV start treatment?
- What does treatment as prevention mean about the best time to start HIV treatment?
- Should everyone with HIV start ARVs right away—even before they feel sick or the CD4 cell count drops?
- If you start ARVs and want to use them as treatment as prevention, do you have to stay on them for life?
- Many countries don’t have viral load tests in public facilities. How can an individual tell if treatment as prevention is working—especially if he or she is feeling healthy anyway?
- There are treatment shortages in many countries. Why should PLHIV push for expanding access for treatment as prevention?
- Adolescents Living with HIV (ALHIV) Toolkit
- Toolkit for Transition of Care and Other Services for Adolescents Living with HIV
- Optimizing Entry Into and Retention in HIV Care and ART Adherence for PLWHA
- Consolidated Guideline on Sexual and Reproductive Health and Rights of Women Living with HIV
- Positive Connections: Leading Information and Support Groups for Adolescents Living with HIV
- Engaging Men in HIV and AIDS at the Service Delivery Level
- Guidance for the Prevention of Sexually Transmitted HIV Infections
- Promoting the Health of Men who Have Sex with Men Worldwide: A Training Curriculum for Providers
- Oral Pre-Exposure Prophylaxis- Questions and Answers
- Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents